Imugene Limited (ASX:IMU), a clinical-stage immuno-oncology company headquartered in Sydney, has released updated results from its ongoing Phase 1b clinical trial of azer-cel (azercabtagene zapreleucel) in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). The trial is investigating azer-cel, an allogeneic (off-the-shelf) …

Stavely Minerals Limited (ASX:SVY)has reported initial assay results from its recent gold-focused reverse circulation (RC) drilling and exploration work at the Fairview South prospect, part of its 100%-owned Stavely Copper-Gold Project in western Victoria. The early-stage results, which include both drilling and rock-chip sampling, …

Shares of several ASX-listed companies opened the trading week on a positive trajectory, contributing to a modest recovery in the S&P/ASX 200 Index. By mid-morning, the benchmark index was up 0.15% to 8,592.5 points, recovering from a weaker start. Notably, Abacus Storage King Ltd, …